Idera Pharmaceuticals Announces FDA Authorization to Proceed with a Phase 2 ... - MarketWatch (press release)

Mass High school Idera Pharmaceuticals Announces FDA Authorization to Proceed with a Phase 2 ... MarketWatch (press release) "We are pleased to wealthy person the FDA's notification that we can proceed with a Phase 2 clinical trial of IMO-3100 in patients with psoriasis ," said Sudhir Agrawal, D.Phil., Chairman and Chief Executive Officer of Idera. "We are now preparing for this Phase ... Idera Pharmaceuticals Announces FDA authorisation to Proceed with type A Phase 2 ... Benzinga all 46 news articles » Link To Article